A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.
about
Coadministration of indinavir and nelfinavir in human immunodeficiency virus type 1-infected adults: safety, pharmacokinetics, and antiretroviral activity.Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART.Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.A review of nelfinavir for the treatment of HIV infection.Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?ADME pathway approach for pharmacogenetic studies of anti-HIV therapy.Clinical pharmacokinetics of antiretroviral drugs in older persons.The role of cytochrome P450 in antiretroviral drug interactions.Screening of FDA-Approved Drugs for Inhibitors against Japanese Encephalitis Virus Infection.
P2860
Q34251788-9FC86FBF-A941-4448-B8F2-44596796D78AQ34721793-35017109-A826-4BFE-858C-79406D6CE66EQ35826943-A5046529-7CF3-48B8-94CB-D8FED267CDE5Q36536514-CDD8262F-22AA-42DA-A6AC-0EEA8ADBAA47Q36546278-93088332-3A37-40C3-A23F-905B5F5FA6E3Q36628026-84B023C7-F0AD-4F82-995D-29FB98F8CA72Q36845126-96EC851F-B7E2-420C-8153-33EE7213127AQ36905884-0382C80E-783E-485F-B057-B1AC850CF122Q36909336-FE780C28-1179-4F61-A4CB-11590607F1B6Q38156719-6219C5FC-D849-43AB-9B5E-39D94BCA5FFF
P2860
A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A population pharmacokinetic a ...... in a phase III clinical trial.
@ast
A population pharmacokinetic a ...... in a phase III clinical trial.
@en
type
label
A population pharmacokinetic a ...... in a phase III clinical trial.
@ast
A population pharmacokinetic a ...... in a phase III clinical trial.
@en
prefLabel
A population pharmacokinetic a ...... in a phase III clinical trial.
@ast
A population pharmacokinetic a ...... in a phase III clinical trial.
@en
P2093
P2860
P1476
A population pharmacokinetic a ...... in a phase III clinical trial.
@en
P2093
K A Jackson
M N Dudley
S E Rosenbaum
Y K Pithavala
P2860
P304
P356
10.1128/AAC.44.7.1832-1837.2000
P407
P577
2000-07-01T00:00:00Z